Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2021 Filed Oct 7, 2021 21:45 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 430.4278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059962 · doc4.xml · derivative · entry 20 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,741.7576 Underlying: Common Shares · 430.4278 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F13 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F22 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F22 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:45 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,266.8468 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059962 · doc4.xml · derivative · entry 19 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,232.2951 Underlying: Common Shares · 2,266.8468 shares Expires 2025-02-21 F21 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F17 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:45 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 155.7777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059962 · doc4.xml · derivative · entry 18 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,364.1346 Underlying: Common Shares · 155.7777 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F13 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F20 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F20 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:45 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,568.2491 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059962 · doc4.xml · derivative · entry 17 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,762.6476 Underlying: Common Shares · 2,568.2491 shares Expires 2024-02-22 F19 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F17 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:45 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 134.1373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059962 · doc4.xml · derivative · entry 16 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,813.0178 Underlying: Common Shares · 134.1373 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F13 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F18 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F18 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:45 UTC |
Cil Jose E.Chief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,141.3304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059962 · doc4.xml · derivative · entry 15 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,434.5745 Underlying: Common Shares · 2,141.3304 shares Expires 2023-02-23 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2018 PBRSUs") granted to the Reporting Person. The 2018 PBRSUs had a three-year performance period beginning January 1, 2015 and ending December 31, 2018 and will vest 100% on February 23, 2023, which is the fifth anniversary of the grant date. F17 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:45 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 153.1827 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059962 · doc4.xml · derivative · entry 14 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,058.2139 Underlying: Common Shares · 153.1827 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F13 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F15 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F15 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:45 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 162.9557 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059962 · doc4.xml · derivative · entry 13 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,210.3254 Underlying: Common Shares · 162.9557 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F13 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F14 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:49 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 174.7798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059969 · doc4.xml · derivative · entry 18 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,604.2289 Underlying: Common Shares · 174.7798 shares Expires 2024-02-19 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 91.2246 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059969 · doc4.xml · derivative · entry 17 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,754.1774 Underlying: Common Shares · 91.2246 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 86.0856 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059969 · doc4.xml · derivative · entry 16 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,148.3515 Underlying: Common Shares · 86.0856 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:49 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 226.6847 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059969 · doc4.xml · derivative · entry 15 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,723.1295 Underlying: Common Shares · 226.6847 shares Expires 2025-02-21 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 67.7424 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059969 · doc4.xml · derivative · entry 14 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,985.94 Underlying: Common Shares · 67.7424 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:49 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 466.9544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059969 · doc4.xml · derivative · entry 12 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,047.7541 Underlying: Common Shares · 466.9544 shares Expires 2024-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 79.8679 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059969 · doc4.xml · derivative · entry 11 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,415.3679 Underlying: Common Shares · 79.8679 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 93.949 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059969 · doc4.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,075.341 Underlying: Common Shares · 93.949 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 114.2174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059969 · doc4.xml · derivative · entry 8 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,464.7189 Underlying: Common Shares · 114.2174 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 40.4428 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059965 · doc4.xml · derivative · entry 12 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,767.675 Underlying: Common Shares · 40.4428 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 130.4327 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059965 · doc4.xml · derivative · entry 11 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,376.2902 Underlying: Common Shares · 130.4327 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 90.6739 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059965 · doc4.xml · derivative · entry 10 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,689.2518 Underlying: Common Shares · 90.6739 shares Expires 2025-02-21 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 33.1322 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059965 · doc4.xml · derivative · entry 9 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,905.8526 Underlying: Common Shares · 33.1322 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 186.7818 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059965 · doc4.xml · derivative · entry 8 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,019.1016 Underlying: Common Shares · 186.7818 shares Expires 2024-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 41.2227 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059965 · doc4.xml · derivative · entry 7 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,859.6157 Underlying: Common Shares · 41.2227 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 33.6551 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059965 · doc4.xml · derivative · entry 6 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,967.4898 Underlying: Common Shares · 33.6551 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 46.8544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059965 · doc4.xml · derivative · entry 4 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,523.5151 Underlying: Common Shares · 46.8544 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Kobza JoshuaCOO
|
GrantPerformance Share Units · Derivative | 728.2491 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059966 · doc4.xml · derivative · entry 14 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,850.9536 Underlying: Common Shares · 728.2491 shares Expires 2024-02-19 F15 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 170.3538 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059966 · doc4.xml · derivative · entry 13 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,082.4601 Underlying: Common Shares · 170.3538 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 358.6899 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059966 · doc4.xml · derivative · entry 12 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,284.798 Underlying: Common Shares · 358.6899 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Kobza JoshuaCOO
|
GrantPerformance Share Units · Derivative | 1,813.4774 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059966 · doc4.xml · derivative · entry 11 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,785.0361 Underlying: Common Shares · 1,813.4774 shares Expires 2025-02-21 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 131.0691 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059966 · doc4.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,451.3135 Underlying: Common Shares · 131.0691 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Kobza JoshuaCOO
|
GrantPerformance Share Units · Derivative | 2,101.2947 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059966 · doc4.xml · derivative · entry 9 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,714.8935 Underlying: Common Shares · 2,101.2947 shares Expires 2024-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 124.3313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059966 · doc4.xml · derivative · entry 8 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,657.015 Underlying: Common Shares · 124.3313 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 164.9118 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059966 · doc4.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,440.9273 Underlying: Common Shares · 164.9118 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:47 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 196.3395 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059966 · doc4.xml · derivative · entry 5 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,145.8299 Underlying: Common Shares · 196.3395 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 68.2424 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059970 · doc4.xml · derivative · entry 11 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,044.875 Underlying: Common Shares · 68.2424 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance baserd restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 114.7808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059970 · doc4.xml · derivative · entry 10 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,531.1354 Underlying: Common Shares · 114.7808 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 362.6955 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059970 · doc4.xml · derivative · entry 9 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,757.0072 Underlying: Common Shares · 362.6955 shares Expires 2025-02-21 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance baserd restricted share units to which they relate. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 24.618 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059970 · doc4.xml · derivative · entry 8 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,902.1319 Underlying: Common Shares · 24.618 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 50.1696 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059970 · doc4.xml · derivative · entry 6 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,914.3307 Underlying: Common Shares · 50.1696 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 55.4846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059970 · doc4.xml · derivative · entry 4 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,540.9046 Underlying: Common Shares · 55.4846 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:50 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 78.2176 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059970 · doc4.xml · derivative · entry 2 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,220.8181 Underlying: Common Shares · 78.2176 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F3 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 21:48 UTC | GrantPerformance Share Units · Derivative | 291.2997 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059967 · doc4.xml · derivative · entry 15 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,340.3814 Underlying: Common Shares · 291.2997 shares Expires 2024-02-19 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
|
| October 05, 2021 Filed Oct 7, 2021 21:48 UTC | GrantRestricted Share Units · Derivative | 86.6595 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059967 · doc4.xml · derivative · entry 14 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,216.0072 Underlying: Common Shares · 86.6595 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
|
| October 05, 2021 Filed Oct 7, 2021 21:48 UTC | GrantRestricted Share Units · Derivative | 143.4759 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059967 · doc4.xml · derivative · entry 13 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,913.9192 Underlying: Common Shares · 143.4759 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
|
| October 05, 2021 Filed Oct 7, 2021 21:48 UTC | GrantPerformance Share Units · Derivative | 453.3694 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059967 · doc4.xml · derivative · entry 12 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,446.259 Underlying: Common Shares · 453.3694 shares Expires 2025-02-21 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
|
| October 05, 2021 Filed Oct 7, 2021 21:48 UTC | GrantRestricted Share Units · Derivative | 66.9627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059967 · doc4.xml · derivative · entry 11 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,894.0125 Underlying: Common Shares · 66.9627 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
|
| October 05, 2021 Filed Oct 7, 2021 21:48 UTC | GrantPerformance Share Units · Derivative | 933.9088 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059967 · doc4.xml · derivative · entry 9 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,095.5082 Underlying: Common Shares · 933.9088 shares Expires 2024-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
|
| October 05, 2021 Filed Oct 7, 2021 21:48 UTC | GrantRestricted Share Units · Derivative | 60.7041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059967 · doc4.xml · derivative · entry 8 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,156.208 Underlying: Common Shares · 60.7041 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
|
| October 05, 2021 Filed Oct 7, 2021 21:48 UTC | GrantRestricted Share Units · Derivative | 18.7647 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059967 · doc4.xml · derivative · entry 7 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,212.1142 Underlying: Common Shares · 18.7647 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
|
| October 05, 2021 Filed Oct 7, 2021 21:48 UTC | GrantRestricted Share Units · Derivative | 25.3111 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059967 · doc4.xml · derivative · entry 3 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,983.8489 Underlying: Common Shares · 25.3111 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.